Sponsored by:

Nuclear Medicine: Page 74

Week in Review: Welcome to the trade war | Molybdenum woes | Risk-based breast screening
By Brian Casey
July 5, 2018
Can deep learning monitor lesions on F-18 NaF PET/CT?
By Erik L. Ridley
Deep learning can classify bone lesions found on F-18 sodium fluoride (NaF) PET/CT exams, potentially enabling monitoring of individual lesions and faster interpretation times, according to research presented recently at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Philadelphia.
July 4, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
Cardiac hybrid imaging predicts adverse cardiac events
By Abraham Kim
A cardiac hybrid imaging technique that fuses SPECT myocardial perfusion imaging with coronary CT angiography scans can help predict major adverse cardiac events in patients suspected of having coronary artery disease, according to a study published online July 3 in Radiology.
July 3, 2018
2018 07 03 16 22 0383 Cardiac Hybrid Image 20180703164402
Novel nanoSPECT/CT radionuclide could aid cancer therapy
By Wayne Forrest
Swedish and Dutch researchers are reporting early progress in combining nanoSPECT/CT with a novel pretargeted radionuclide therapy for cancer that so far is nontoxic to the kidneys, according to a preclinical study published in the July issue of the Journal of Nuclear Medicine.
July 2, 2018
2018 07 02 21 04 7999 Jnm Mice Nano Spect Ct Image 215
Alliance Medical Group acquires Piramal Imaging
By AuntMinnie.com staff writers
The Alliance Medical Group has reached an agreement to acquire Piramal Imaging, which includes its two subsidiaries -- Piramal Imaging Ltd. and Piramal Imaging GmbH -- and its U.S. business.
July 1, 2018
2018 07 02 17 03 9361 Piramal Thumbnail 400
Start-up to develop arthritis molecular imaging agent
By AuntMinnie.com staff writers
U.K. life sciences developer Serac Life Sciences has established a new company, Serac Healthcare, to develop a molecular imaging agent that will help rheumatologists manage treatment for their arthritis patients.
June 27, 2018
SNMMI: AI enables stress-first SPECT MPI protocol
By Erik L. Ridley
PHILADELPHIA - Artificial intelligence (AI) analysis of stress SPECT myocardial perfusion imaging (MPI) can be highly sensitive for all types of coronary artery disease, according to research presented Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2016 09 20 16 53 46 654 Heart Scan 400
Live from SNMMI 2018: Update on radiopharmaceuticals
What's going on in the world of medical isotopes? From molybdenum supply to reimbursement, there is no lack of issues facing the Council for Radionuclides and Radiopharmaceuticals (CORAR). Michael Guastella, CORAR’s executive director, spoke with AuntMinnie.com Features Editor Wayne Forrest during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2018 06 26 22 53 2124 Guastella Michael
SNMMI: Theranostic agent awarded Image of the Year
By Wayne Forrest
PHILADELPHIA - A PET image that shows the combined power of the diagnostic and therapeutic (theranostic) use of molecular imaging to identify and treat metastatic castration-resistant prostate cancer has been named this year's Image of the Year at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2018 06 26 22 57 6437 2018 06 26 Snmmi Image Of The Year 20180626220706
Live from SNMMI 2018: Nuclear medicine and patients
Patients justifiably are the centers of attention in imaging procedures, and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) is reaching out to them through the formation of a patient advocacy advisory board. In this video from SNMMI 2018, AuntMinnie.com Features Editor Wayne Forrest speaks with Josh Mailman, inaugural chair of the board.
June 26, 2018
2018 06 26 20 55 9981 Mailman Josh
SNMMI: Cerebrovascular risk tied to Alzheimer's disease
By Wayne Forrest
PHILADELPHIA - A study on amyloid plaque accumulation, white-matter hyperintensity, and cortical thickness has found that a patient's cerebrovascular characteristics should be considered for their potential effect on the progression of Alzheimer's disease. The findings were presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2017 04 14 10 55 26 413 Brain General 400
SNMMI: Early prostate cancer therapy extends lives
By Erik L. Ridley
PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand therapy earlier to patients with metastatic prostate cancer can extend lives, according to research presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 26, 2018
2018 06 25 22 13 1249 Lutetium 20180625221346
Previous Page
Page 74 of 438
Next Page